UNCY
Unicycive Therapeutics Inc
4.10$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.5% | 94.4% | 98.6% | 98.6% | 97.8% | 97.7% | 97.8% | 98.4% | 99.4% | 99.6% | 98.7% | 99.0% | |
| 73.8% | 68.4% | 93.4% | 93.5% | 83.9% | 82.6% | 70.7% | 74.4% | 84.4% | 59.4% | 58.0% | 61.3% | |
| 73.8% | 68.4% | 93.4% | 93.5% | 83.9% | 82.6% | 70.7% | 74.4% | 84.4% | 84.0% | 84.8% | 85.3% | |
| 82.3% | 126.8% | 58.5% | 29.9% | 27.8% | 76.5% | 59.7% | 45.2% | 25.9% | 38.5% | 41.5% | 26.0% | |
| 79.5% | 123.6% | 57.8% | 29.3% | 27.1% | 76.2% | 59.7% | 45.2% | 25.9% | 38.5% | 41.1% | 26.0% | |
| 1.6% | 2.4% | 0.7% | 0.8% | 1.4% | 2.1% | 2.5% | 1.6% | 1.0% | 0.4% | 1.1% | 0.9% | |
| 5.1% | 5.8% | 2.2% | 3.1% | 1.4% | 3.1% | 4.5% | 2.4% | 1.4% | 0.6% | 1.6% | 3.1% | |
| 17.7% | -26.8% | 41.5% | 70.1% | 72.2% | 23.5% | 40.3% | 54.8% | 74.1% | 61.5% | 58.5% | 74.0% | |
| -291.9% | -454.8% | -163.2% | -169.2% | -206.7% | -319.8% | -360.3% | -357.2% | -223.6% | -260.2% | -218.4% | -197.7% | |
| 16.8% | 24.5% | 6.7% | 8.5% | 23.1% | 24.6% | 44.3% | 41.0% | 35.7% | 40.5% | 37.1% | 37.4% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.